Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

MOms in REcovery (MORE) Study: Defining Optimal Care

A legfontosabb adatok

Ki végzi
Trustees of Dartmouth College
Hol
Augusta, Bangor, Bennington, Berlin Corners, Brattleboro, Keene, Lebanon, Manchester és Nashua (Egyesült Államok)Mind a 10 helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
2510 fő vett részt
Kezdés
2019. júl. 30.
Befejezés
2024. jan. 31.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Observational Study
A regiszteradat frissítve
2026. október 23.

Ki vehet részt

Életkor
16 év – 50 év
Nem
Csak nők
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 16 year and older,
  • Identified opioid use disorder,
  • Receiving prenatal care for current pregnancy at partner practice,
  • Clinic-recorded diagnosis of opioid use disorder,
  • Willing and able to provide informed consent

Ki nem vehet részt

  • Ward of the State

Helyszínek itt: Egyesült Államok

  • Maine General HospitalAugusta, Egyesült Államok
  • Eastern Maine Medical Center/Northern LightBangor, Egyesült Államok
  • Southwestern Vermont Medical Center OB-GYNBennington, Egyesült Államok
  • Central Vermont Medical CenterBerlin Corners, Egyesült Államok
  • Brattleboro Memorial Hospital OB-GYNBrattleboro, Egyesült Államok
  • Dartmouth Hitchcock Keene/Cheshire Medical Center OB-GYNKeene, Egyesült Államok
  • Dartmouth Hitchcock Addiction Treatment, Moms in RecoveryLebanon, Egyesült Államok
  • Dartmouth-Hitchcock Medical Center-OB/GYNLebanon, Egyesült Államok
  • Dartmouth Hitchcock Bedford/ManchesterManchester, Egyesült Államok
  • Dartmouth Hitchcock Nashua OB-GYNNashua, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

Northern New England has among the highest rates of opioid dependence in the U.S. This region also has among the highest rates of opioid-related deaths in the U.S., with a disproportionate high rate among pregnant women with opioid use disorder. Newborns impacted by OUD have increased risk of poor outcomes, including preterm birth and long hospitalization for neonatal withdrawal and other newborn complications. For pregnant women with OUD, medication treatment (MOUD) significantly reduces these risks. Many maternity care providers have begun to prescribe MOUD in their practices. Other practices have maintained the longstanding evidence-based standard of care, referral of patients with OUD to specialty treatment programs. Most pregnant women with OUD have other psychosocial needs, ranging from lack of housing and untreated mental health conditions, to need for parenting education and support. There is variability among practices in terms of types of other services provided to patients. Although pregnancy is a time when women are highly motivated to start MOUD, many women are also likely to discontinue MOUD postpartum due to loss of insurance coverage, difficulty transitioning to another provider, loss of motivation for treatment, or competing demands on time and resources as a new parent.

A teljes eredeti leírásKevesebb

The challenge for patients, providers, and other stakeholders is to understand the relative advantage of the two MOUD models (receiving MOUD as part of maternity care or at a specialty program) for improving key outcomes for baby \& mother. A second challenge is to understand the relative contributions of onsite services such as mental health care, care coordination and parenting education to improved outcomes. Addressing these challenges is particularly important in rural areas where obstetric practices \& specialty care services are limited. Patients, providers \& other stakeholders need guidance in choosing the optimal models for building programs to provide maternity care for women with OUD.

A vizsgálat 2 csoportja

  • Integrated Care

    This is an observational study and no intervention will be administered. The Integrated Cohort consists of pregnant women with identified opioid use disorder who are receiving prenatal care in a maternity setting that provides medication assisted treatment for opioid use.

    Kezelés: Observational Study

  • Referral-Based Care

    This is an observational study and no intervention will be administered. The Referral-Based Cohort consists of pregnant women with identified opioid use disorder who are receiving prenatal care in a maternity setting and are referred to substance use treatment at a specialty care setting.

    Kezelés: Observational Study

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
MOms in REcovery (MORE): Defining Optimal Care for Pregnant Women and Infants
A regiszteradat frissítve
2026. október 23.